Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection

Cytokine-induced killer (CIK) cell therapy has recently been used as an adjuvant setting following resection of hepatocellular carcinoma (HCC), while its benefit remains unclear. This study aimed to evaluate the efficacy of adjuvant CIK application in solitary HCC patients undergoing curative resect...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Medicine (Baltimore)
المؤلفون الرئيسيون: Chen, Jian-Lin, Lao, Xiang-Ming, Lin, Xiao-Jun, Xu, Li, Cui, Bo-Kang, Wang, Jun, Lin, Guo-He, Shuang, Ze-Yu, Mao, Yi-Ze, Huang, Xin, Yun, Jing-Ping, Jin, Jie-Tian, Li, Sheng-Ping
التنسيق: Artigo
اللغة:Inglês
منشور في: Wolters Kluwer Health 2016
الموضوعات:
7300
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4748913/
https://ncbi.nlm.nih.gov/pubmed/26844496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000002665
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة